Adamas Pharmaceuticals Inc.
06/23/2021 | Press release | Distributed by Public on 06/23/2021 14:43
Adamas to Present at Upcoming SVB Leerink CNS Forum
EMERYVILLE, Calif.--(BUSINESS WIRE)-- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that the company will present 'What's Happening in Parkinson's Disease & the GOCOVRI Opportunity' at the SVB Leerink CNS Forum on Tuesday, June 29th at 1:10 pm Eastern Time.
The presentation will be broadcast live from the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. Replays of the event will be available for 30 days.
About Adamas Pharmaceuticals, Inc.
At Adamas our vision is clear - to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.
Source: Adamas Pharmaceuticals, Inc.
Media:
Sarah Mathieson
Vice President, Corporate Communications
510-450-3528
[email protected]
Investors:
Peter Vozzo
Managing Director
Westwicke/ICR
443-213-0505
[email protected]